Chronic Fatigue / Cancer-Related Fatigue Secondary to Cancer (Any Service-Connected Malignancy or Treatment)

Yes. Under 38 CFR § 3.310(a), any disability proximately caused or chronically worsened by a service-connected condition is itself service-connected. Chronic Fatigue / Cancer-Related Fatigue is a documented secondary pairing for Cancer (Any Service-Connected Malignancy or Treatment) with strong medical evidence. A nexus letter from a qualified physician linking the two conditions is the most reliable way to establish this connection.

The gold standard is a private nexus opinion stating — to at least a 50% probability ("at least as likely as not") — that the secondary condition was caused or aggravated by the primary service-connected condition. Peer-reviewed medical literature supporting the physiological mechanism strengthens the nexus. Treatment records documenting the onset or worsening of the secondary condition in temporal relation to the primary are supporting evidence.

The VA rates Chronic Fatigue / Cancer-Related Fatigue separately under its own 38 CFR Part 4 diagnostic code, then combines it with Cancer (Any Service-Connected Malignancy or Treatment) and all other service-connected ratings using the combined ratings formula under § 4.25. The formula applies the whole-person concept: a 50% combined existing rating plus a new 30% rating yields 65% (rounded to 70%), not 80%.

38 CFR § 3.310(a) states: "Disability which is proximately due to or the result of a service-connected disease or injury shall be service connected." The aggravation variant under § 3.310(b) applies where the primary condition permanently worsens a pre-existing disability beyond its natural progression. Both standards require a showing of nexus — a medical or scientific link between the primary condition and the secondary.

The medical evidence supporting Chronic Fatigue / Cancer-Related Fatigue as secondary to Cancer (Any Service-Connected Malignancy or Treatment) is rated strong. Cancer-related fatigue (CRF) is the most prevalent, persistent, and distressing symptom experienced by cancer survivors, distinct from ordinary tiredness in its severity, duration, and disproportionate relationship to activity. CRF is rated separately from any underlying psychiatric condition. Pathophysiological mechanisms include: sustained pro-inflammatory cytokine elevation (IL-6, TNF-alpha, IL-1beta) from tumor presence and treatment-related immune activation causing neuroimmunological fatigue; HPA axis dysregulation with cortisol rhythm disruption; anemia from chemotherapy-induced bone marrow suppression; cancer- and treatment-induced hypothyroidism or adrenal insufficiency; deconditioning from activity restriction; and direct central neurotoxic effects of chemotherapy. CRF persists years to decades after cancer treatment in a significant subset, representing a chronic functional impairment rateable under VA disability schedules.

The VA will not solicit nexus evidence on your behalf for secondary claims. In practice, a written nexus opinion from a private physician or independent medical examiner is essential — the VA's Compensation & Pension (C&P) examiner is not required to produce a favorable nexus opinion, and the VA has discretion to weigh competing opinions. Submitting a private nexus letter at the time of filing is the most reliable strategy.